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ABSTRACT 
The present study was undertaken with an aim to develop and evaluate gastroretentive floating tablets of Metronidazole  that are 
designed to retain in the stomach for a long time and have developed as a drug delivery system for better eradication of Helicobacter 
Pylori in peptic ulcer diseases. The floating tablets of Metronidazole were made by direct compression method using polymer 
Carbopol 934 and sodium bicarbonate and citric acid as gas generating agent. The tablets were evaluated by pre and post 
compression parameters such as weight variation, thickness, friability, hardness, drug content, in- vitro buoyancy studies and in-vitro 
dissolution studies and results were within the limits. Hardness was found to be in the range of 7.6 ± 0.27 kg/ cm² to 7.9 ± 0.35 
kg/cm², the percent friability was in the range of 0.48% to 0.52% w/w and the tablets showed 94%  to 97% uniformity in drug 
content. The in-vitro dissolution studies were carried out in a USP type- II apparatus in 0.1N HCl. The formulations were able to 
within 2-7 minutes and showed buoyancy >12 hrs. The drug-polymer ratio, viscosity grades of Carbopol 934 and gas generating 
agents were found to influence the release of drug and floating characteristics from the prepared floating drug delivery system of 
Metronidazole. Kinetically, among the 4 assessed models the release pattern of Metronidazole from the tablets fitted best to 
Higuchi’s and zero order indicated that diffusion is the predominant mechanism controlling the drug release. 
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INTRODUCTION 
Controlled release dosage forms is the part of modified 
drug release dosage form which covers a wide range of 
prolonged action which provide continuous release of 
their active ingredients at predetermined rate and 
predetermined time
1, 2
.  
Since many drugs are well absorbed in the upper part of 
the gastrointestinal tract, such high variability may lead 
to non-uniform absorption and makes the bioavailability 
unpredictable. Hence a beneficial delivery system would 
be one which possesses the ability to control and prolong 
the gastric emptying time and can deliver drugs in higher 
concentrations to the absorption site (i.e. upper part of 
the small intestine) 
 3, 4
. 
Out of various controlled drug delivery systems floating 
drug delivery system utilizes principle of gastric 
retention time of the dosage forms at the stomach and 
upper part of the small intestine and suitable for the drug 
having site-specific absorption from the above sites and 
control the delivery of active ingredients. 
5, 6
.  
Floating Drug Delivery System (FDDS) have a bulk 
density less than gastric fluids and so remain buoyant in 
the stomach without affecting the gastric emptying rate 
for a prolong period of time. While the system is floating 
on the gastric content, the drug is released slowly at the 
desired rate from the system.
7, 8, 9
,
 10
 
Metronidazole is a synthetic antibacterial and 
antiprotozoal agent that belongs to the nitroimidazole 
class. It is indicated for the treatment of Helicobacter 
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Pylori eradication therapy, as a part of multi drug 
regimen in peptic ulcer disease. It is usually taken two or 
three times a day. Administration of prolonged release 
floating tablet will result in prolonged retention of drug 
in the gastric fluid. Thus, resulting in complete 
dissolution of drug in extended period of time by 
enhancing the drug absorption and thereby reduces the 
dosing frequency of the drug in therapy
7, 11
. 
MATERIALS AND METHODS 
Metronidazole was received as generous gift fron Zydus- 
Cadila, Ahemdabad India. Carbopol 934, 
microcrystalline cellulose, sodium starch glycolate, 
lactose were received from Loba Chemie pvt. Ltd. 
Mumbai. Citric acid received from S.D. Fine Chem. 
Limited, Mumbai. All other chemicals used were of 
analytical reagent grade, available commercially and 
used as such without further processing. 
Methods: The excipients Carbopol 934 is used as 
polymer, sodium bicarbonate as effervescent mixture, 
lactose as diluent. 
Compression of tablets 
After pre compression evaluation the powder was 
directly compressed into tablet using punch tablet 
machine
7, 10
. 
Evaluation of tablets: 
Hardness
7, 10
:  
The hardness was determined by Monsanto hardness 
tester. It is expressed in kg/cm
3. 
Weight variation
7, 10
: 
20 tablets were selected at random and weighed 
collectively and individually. From the collective weight 
average weight was calculated. Each tablet was then 
compared with the average weight. 
Thickness and diameter: 
The thickness and diameter of the tablets were 
determined by Vernier calliper. It is expressed in mm. 
Friability
7, 10
: 
Friability is determined by Roche friabilator. It is 
expressed in percentage. The friabilator was operated at 
25 rpm per min. for 4 minutes (100 revolutions). The 
tablets were initially weighed (WINITIAL) and transferred 
into the friabilator. The tablets were than weighed 
(WFINAL) again after operating the friabilator. The % 
friability was calculated by the formula: 
Percentage friability = WINITIAL-WFINAL /WINITIAL*100 
Content uniformity: 
20 tablets of each formulation were weighed and 
powdered. The quantity equivalent to 100 mg of 
metronidazole was transferred into a 100ml of 
volumetric flask and the volume was adjusted to 100ml 
with 0.1N HCl. Further 1ml of the above solution was 
diluted to 100ml with 0.1N HCl and the absorbance of 
the solution was observed at 273nm. 
In- vitro buoyancy study: 
The in-vitro buoyancy was determined by floating lag 
time and total floating time. The tablets were placed in a 
100ml beaker containing 0.1N HCl. The time required 
for the tablet to rise to the surface and float was 
deyermined by floting lag time and the duration of the 
time the tablet contantly floats on the dissolution 
medium was noted as total floating time. 
Dissolution study
7, 10
: 
 elease studies  ere performed in      as et method  
   ml of      H l  as placed in the  essel and the 
medium  as allo ed to e uili rate to the temperature of 
        C. Tablet was placed in the vessel and the paddle 
was operated at 75 rpm. At definite time intervals, 5ml 
of the fluid was withdrawn; filtered and again 5ml of the 
fluid was replaced. Suitable dilutions were done with the 
dissolution fluid and the samples were analyzed 
spectrophotometrically. 
Drug Release kinetics: 
To analyze the mechanism of drug release from the 
prepared formulations, the data obtained from in- vitro 
release studies  ere su jected to zero order, Higuchi’s 
model and  orsmeyer’s model  
RESULTS AND DISCUSSION 
Formulation of floating tablet: 
In the present study, floating tablets of metronidazole 
were prepared by using Carbopol, microcrystalline 
cellulose (MCC) and sodium bicarbonate and citric acid 
as effervescent agent. 
Floating tablets of metronidazole were developed to 
increase the gastric residence time of the drug, so that 
they can be retained in stomach for longer time resulting 
in controlled release of drug. A total number of three 
formulations (Table 1) were prepared by direct 
compression method. 
Table 1: formulation tablet of floating tablet of 
Metronidazole 
S.N. Ingredients(mg) FM1 FM2 FM3 
1 Metronidazole 200 200 200 
2 Carbopol 100 150 200 
3 MCC 10 10 10 
4 Sodium starch 
glycolate 
25 25 25 
5 Sodium 
bicarbonate 
60 60 60 
6 Citric acid  15 15 15 
7 Lactose  90 40 - 
 
Pre compression studies: 
The pre compression studies such as bulk density, 
tapped density, angle of repose, compressibility index 
were evaluated which were found to be within 
prescribed limits (Table 2). 
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Table 2: Pre compression study data 
 
 
 
 
Post compression studies: 
The data obtained from physicochemical parameters such as hardness, friability, weight variation, drug content were in 
acceptable range (Table 3). 
Table 3: Post compression studies 
S.No. Hardness 
kg/cm
2 
Friability loss 
in% 
Weight variation 
(mg) 
Uniformity drug 
content (%) 
Thickness 
(mm) 
Diameter 
(mm) 
FM1 6.6 0.6 498 96 4.6 10.6 
FM2 8.2 0.5 480 94.5 5.3 10.4 
FM3 7.4 0.7 478 95 5.8 10.5 
 
In vitro buoyancy study: 
The in vitro buoyancy was determined by floating lag 
time. The tablets were placed in a 100ml beaker 
containing 0.1N HCl. The time required by the tablet to 
rise to the surface and float was determined as floating 
lag time (Table 4). 
Table 4: In vitro buoyancy study 
 
 
 
 
In vitro dissolution study and release kinetics: 
The release rate of metronidazole from floating tablets 
was determined using United States Pharmacopoeia 
(USP) 24 XXIV dissolution testing apparatus 2 (paddle 
method). The in vitro dissolution revealed that the 
formulation FM1 and FM2 released the drug faster as 
compared to formulation FM3. This is because a weak 
layer of gel around the tablet was formed in FM1 and 
FM2 formulation containing 100mg and 150mg that 
results in 85.28% and 80.25% of release of drug 
respectively. In case of FM3 formulation containing 
200mg drug, a dense layer is formed that release that 
provides a delayed release of drug. Hence provides 
sustained release.  
The curve fitting results of the in vitro release data of the 
formulations indicated that Higuchi model (Table 5) is 
the best fit to describe the release of drug from matrix 
floating tablet and the mechanism of drug release was 
diffusion. 
                                    
 
Figure 1: Cumulative drug release 
Table 5: Release kinetics of different formulation 
 
 
 
 
 
CONCLUSION 
This study discusses the preparation of floating tablets of 
metronidazole. The effervescent based floating drug 
delivery was a promising approach to achieve in vitro 
buoyancy. The addition of polymer Carbopol, HPMC 
and gas generating agent sodium bicarbonate and citric 
acid were essential to achieve in vitro buoyancy. The 
polymer composition affects the release of drug. It was 
also demonstrated that the release of drug can be 
changed by modifying the type and amount of polymer 
in the matrix tablets. 
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Series1 
Series2 
S.No.  Bulk density  Tapped density  Compressibility index (%) 
FM1 0.464 0.543 15.12 
FM2 0.479 0.512 18.94 
FM3 0.483 0.563 14.20 
Formulation Floating lag time (sec.) 
FM1 190 
FM2 200 
FM3 210 
Batches  Zero order  Higuchi model 
 R
2 
R
2 
FM1 0.995 0.925 
FM2 0.997 0.873 
FM3 0.990 0.895 
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